CompletedNCT00283322
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
Studying Classic heparin-induced thrombocytopenia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The University of Texas Health Science Center, Houston
- Principal Investigator
- Robert L Levine, MDThe University of Texas, Houston
- Intervention
- blood samples (2)(other)
- Enrollment
- 185 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2006
Study locations (2)
- Florida Hospital Center for Hemostasis & Thrombosis (Laboratory), Orlando, Florida, United States
- UT-Houston/Memorial Hermann Hospital, Houston, Texas, United States
Collaborators
GlaxoSmithKline
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00283322 on ClinicalTrials.govOther trials for Classic heparin-induced thrombocytopenia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06727500Effects of HIIT and Concurrent HITT/Plyometric Training on Muscle-tendon Structure, Function and Metabolism in Pediatric Population With Obesity at Different Biological Maturation States (HIIT-PRO Kids).Universidad Nacional Andres Bello
- ACTIVE NOT RECRUITINGNCT05092282HITT for the Identification of Mild Traumatic Brain InjuryRebiscan, Inc.
See all trials for Classic heparin-induced thrombocytopenia →